Journal of the National Cancer Institute

Oncology & Cancer

Multi-center study sheds light on understudied breast cancer type

A multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later ...

Oncology & Cancer

Identifying the underlying causes of ovarian cancer

Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women's tumors do not respond to therapy.

Oncology & Cancer

Out-of-pocket costs for cancer care keep climbing

Cancer patients already have a lot to deal with emotionally and physically. But research shows that insured patients under 65 are also paying more for their treatments out-of-pocket than ever before.

Oncology & Cancer

Improving melanoma diagnostic tools

New QIMR Berghofer research has identified a dramatic increase in the treatment of "pre-cancerous" melanomas in Australia and found strong evidence that similar trends are emerging across the globe.

Oncology & Cancer

Variants in BRCA1/2 and MMR genes in children with cancer

Pathogenic variants in BRCA1/2 genes are associated with an increased risk of breast and ovarian cancer in adults, and variants in mismatch repair (MMR) genes increase the risk of gastrointestinal and other cancers. Until ...

Oncology & Cancer

Genetics may predict bladder cancer immunotherapy response

Investigators from Cedars-Sinai Cancer have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to immunotherapy. Their results, published today in the Journal ...

page 4 from 40